1357 studies found for:    "familial atrial fibrillation" OR "Atrial Fibrillation"
Show Display Options
Rank Status Study
21 Terminated Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology or Drug Therapy for Patients With AF Requiring Mitral Valve Surgery
Conditions: Mitral Valvulopathy;   Atrial Fibrillation
Interventions: Device: EPICOR;   Drug: Amiodarone
22 Completed A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)
Condition: Atrial Fibrillation
Interventions: Procedure: Circumferential Pulmonary Vein Ablation;   Drug: Antiarrhythmic Drug Therapy
23 Recruiting Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence
Condition: Atrial Fibrillation
Interventions: Procedure: Wide area circumferential catheter ablation;   Procedure: Augmented- wide area circumferential ablation procedure
24 Recruiting Swiss Atrial Fibrillation Cohort Study
Condition: Atrial Fibrillation
Intervention:
25 Completed
Has Results
Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit
Condition: Atrial Fibrillation
Interventions: Drug: amiodarone;   Drug: Placebo
26 Unknown  Atrial Fibrillation and the Risk for Neurological Complications
Condition: Atrial Fibrillation
Intervention:
27 Completed
Has Results
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
Conditions: Heart Diseases;   Arrhythmia;   Atrial Fibrillation
Intervention: Device: THERMOCOOL® SMARTTOUCH™ Catheter
28 Unknown  Organization of Excitation in People With Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention:
29 Recruiting Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation
Conditions: Paroxysmal Atrial Fibrillation;   Persistent Atrial Fibrillation
Interventions: Procedure: Pulmonary vein isolation;   Drug: Botulinum Toxin
30 Recruiting Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Interrupted apixaban;   Drug: Uninterrupted apixaban
31 Recruiting Atrial Fibrillation Prediction Trial.
Condition: Atrial Fibrillation
Intervention:
32 Completed
Has Results
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Conditions: Heart Diseases;   Arrhythmia;   Atrial Fibrillation
Interventions: Device: NAVISTAR® THERMOCOOL® Catheter;   Drug: Antiarrhythmic drug
33 Completed
Has Results
Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study
Condition: Atrial Fibrillation
Interventions: Device: Cardioblate System Surgical Ablation System;   Procedure: Surgical RF Ablation
34 Withdrawn Atrial Fibrillation Screening With a Smartphone Device and iECG Application
Condition: Atrial Fibrillation
Intervention: Other: AF screening
35 Unknown  Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
Condition: Atrial Fibrillation
Intervention: Device: Mobile Cardiac Outpatient Telemetry
36 Completed
Has Results
Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent
Condition: Atrial Fibrillation
Interventions: Device: Cardioblate Surgical Ablation System;   Procedure: Surgical RF Ablation
37 Terminated Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: Catheter ablation;   Procedure: Thoracoscopic epicardial ablation
38 Recruiting Atrial Fibrillation Detected by Continuous ECG Monitoring
Conditions: Atrial Fibrillation;   Stroke;   Hypertension;   Diabetes
Intervention: Device: LOOP recorder (Medtronic LINQ device)
39 Completed RATe Control in Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Metoprolol;   Drug: Diltiazem;   Drug: Verapamil;   Drug: Carvedilol
40 Terminated The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)
Condition: Atrial Fibrillation
Intervention: Drug: valsartan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years